Suppliers / Ambition Pharma

Ambition Pharma

India 9 employees Updated 9 July 2026

Ambition Pharma is an API manufacturer based in India. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Customs aggregates show $3K of exports covering 2 molecules to 1 destination in 2025.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Furosemide US FDA 1
Riboflavin US FDA 1

Also appears on these molecule pages

Scale

Year Revenue Exports Destinations
2025 Not reported $3K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Ambition Pharma

Does Ambition Pharma hold a US DMF or a CEP?
Ambition Pharma holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Ambition Pharma make?
2 molecules are on record against Ambition Pharma, including Furosemide and Riboflavin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Ambition Pharma?

Ask Fred what the record holds on Ambition Pharma, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts